9 Meters Biopharma triggers reverse stock split to maintain Nasdaq listing


A Raleigh company once labeled the potential next Salix is fighting to keep its shrinking stock price within Nasdaq compliance.

Previous Annapolis firm creating device to treat migraines raising $7M
Next Kickin’ it in style: Sneaker Con Phoenix draws large crowd to revel in basketball culture